D-BMAP18 Antimicrobial Peptide Is Active In vitro, Resists to Pulmonary Proteases but Loses Its Activity in a Murine Model of Pseudomonas aeruginosa Lung Infection
The spread of antibiotic resistant-pathogens is driving the search for new antimicrobial compounds. Pulmonary infections experienced by cystic fibrosis (CF) patients are a dramatic example of this health-care emergency. Antimicrobial peptides could answer the need for new antibiotics but translating...
Main Authors: | Mario Mardirossian, Arianna Pompilio, Margherita Degasperi, Giulia Runti, Sabrina Pacor, Giovanni Di Bonaventura, Marco Scocchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-06-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fchem.2017.00040/full |
Similar Items
-
The Anti-Pseudomonal Peptide D-BMAP18 Is Active in Cystic Fibrosis Sputum and Displays Anti-Inflammatory In Vitro Activity
by: Margherita Degasperi, et al.
Published: (2020-09-01) -
On the Queue Length Distribution in BMAP Systems
by: Andrzej Chydzinski
Published: (2006-12-01) -
Asymptomatic endoalveolar hemorrhage in a young male
by: Alain Kafyeke, et al.
Published: (2016-06-01) -
Prevalence and clinical role of Human Bocavirus in bronchoalveolar lavages of adult patients
by: Stefano Gambarino, et al.
Published: (2010-06-01) -
First Report of the Isolation of Nocardiathailandicafrom the Bronchoalveolar Lavage of a Patient in Iran
by: Samaneh Bourbour, et al.
Published: (2018-09-01)